MiR-29c down-regulation is associated with disease aggressiveness and poor survival in Chinese patients with chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 55, Issue 7, 2014, Pages 1544-1550

  Zhou, Keshu ^a,b   Yu, Zhen ^a   Yi, Shuhua ^a   Li, Zengjun ^a   An, Gang ^a   Zou, Dehui ^a   Qi, Junyuan ^a   Zhao, Yaozhong ^a   Qiu, Lugui ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Chronic lymphocytic leukemia; MicroRNA; Prognosis; Survival

Indexed keywords

BETA 2 MICROGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; MICRORNA; MICRORNA 29C; UNCLASSIFIED DRUG; MIRN29 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CHINESE; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME DELETION; CHROMOSOME DELETION 11Q; CHROMOSOME DELETION 17Q; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; TRISOMY 12; ASIAN CONTINENTAL ANCESTRY GROUP; CANCER STAGING; CASE CONTROL STUDY; CHINA; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MIDDLE AGED; MORTALITY; PROGNOSIS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 84903439787     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.855308     Document Type: Article

References (29)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia.N Engl J Med 2005; 352: 804-815.
2. Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chroniclymphocytic leukemia. Blood 1975; 46: 219-234.
3. Binet JL, Auquier A, Dighiero G, et al. Anew prognostic classifi cationof chronic lymphocytic leukemia derived from a multivariate survivalanalysis. Cancer 1981 ; 48 : 198-206.
4. Hallek M, Wanders L, Ostwald M, et al. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictorsof progression-free survival in chronic lymphocytic leukemia andimmunocytoma. Leuk Lymphoma 1996; 22: 439-447.
5. Meuleman N, Stamatopoulos B, Dejeneffe M, et al. Doubling timeof soluble CD23: a powerful prognostic factor for newly diagnosed anduntreated stage A chronic lymphocytic leukemia patients. Leukemia2008 ; 22 : 1882-1890.
6. Ibrahim S, Keating M, Do K A, et al. CD38 expression as animportant prognostic factor in B-cell chronic lymphocytic leukemia.Blood 2001 ; 98 : 181-186.
7. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genesare associated with a more aggressive form of chronic lymphocyticleukemia. Blood 1999 ; 94 : 1848-1854.
8. Durig J, Nuckel H, Cremer M, et al. ZAP-70 expression is a prognosticfactor in chronic lymphocytic leukemia. Leukemia 2003; 17: 2426-2434.
9. Qiu HX, Xu W, Cao XS, et al. Cytogenetic characterisation inChinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fl uorescencein situ hybridisation. Leuk Lymphoma 2008; 49: 1887-1892.
10. Xu W, Li J Y, Wu Y J, et al. Prognostic signifi cance of ATM and TP53deletions in Chinese patients with chronic lymphocytic leukemia. LeukRes 2008; 32: 1071-1077.
11. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletionsand down-regulation of micro-RNA genes miR15 and miR16 at 13q14in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002 ; 99 :15524-15529.
12. Calin GA, Ferracin M, Cimmino A, et al. AmicroRNA signatureassociated with prognosis and progression in chronic lymphocyticleukemia. NEngl J Med 2005; 353: 1793-1801.
13. Fulci V, Chiaretti S, Goldoni M, et al. Quantitative technologiesestablish a novel microRNA profi le of chronic lymphocytic leukemia.Blood 2007 ; 109 : 4944-4951.
14. Stamatopoulos B, Meuleman N, Haibe-Kains B, et al. microRNA-29c and microRNA-223 down-regulation has in vivo signifi cance inchronic lymphocytic leukemia and improves disease risk stratifi cation.Blood 2009 ; 113 : 5237-5245.
15. Hallek M, Cheson B D, Catovsky D, et al. Guidelines for thediagnosis and treatment of chronic lymphocytic leukemia: a reportfrom the International Workshop on Chronic Lymphocytic Leukemiaupdating the National Cancer Institute-Working Group 1996 guidelines.Blood 2008 ; 111 : 5446-5456.
16. van Dongen JJ, Langerak AW, Brüggemann M, et al. Design andstandardization of PCR primers and protocols for detection of clonalimmunoglobulin and T-cell receptor gene recombinations in suspectlymphoproliferations: report of the BIOMED-2 Concerted ActionBMH4-CT98-3936. Leukemia 2003 ; 17 : 2257-2317.
17. Patz M, Pallasch CP, Wendtner CM. Critical role of microRNAs inchronic lymphocytic leukemia:overexpression of the oncogene PLAG1by deregulated miRNAs. Leuk Lymphoma 2010; 51: 1379-1381.
18. Vasilatou D, Papageorgiou S, Pappa V, et al. The role ofmicroRNAs in normal and malignant hematopoiesis. Eur J Haematol2010 ; 84 : 1-16.
19. Haferlach C, Dicker F, Schnittger S, et al. Comprehensivegenetic characterization of CLL: a study on 506 cases analysed withchromosome banding analysis, interphase FISH, IgV(H) status andimmunophenotyping. Leukemia 2007; 21: 2442-2451.
20. Reddy K S. Chronic lymphocytic leukaemia profi led for prognosisusing a fl uorescence in situ hybridisation panel. Br J Haematol2006 ; 132 : 705-722.
21. Glassman A B, Hayes K J. The value of fl uorescence in situhybridization in the diagnosis and prognosis of chronic lymphocyticleukemia. Cancer Genet Cytogenet 2005 ; 158 : 88-91.
22. Mittal A K, Hegde G V, Aoun P, et al. Molecular basis of aggressivedisease in chronic lymphocytic leukemia patients with 11q deletionand trisomy 12 chromosomal abnormalities. Int J Mol Med 2007 ; 20 :461-469.
23. Athanasiadou A, Stamatopoulos K, Tsompanakou A, et al.Clinical, immunophenotypic, and molecular profi ling of trisomy 12 inchronic lymphocytic leukemia and comparison with other karyotypicsubgroups defi ned by cytogenetic analysis. Cancer Genet Cytogenet2006 ; 168 : 109-119.
24. Visone R, Rassenti L Z, Veronese A, et al. Karyotype-specifi cmicroRNA signature in chronic lymphocytic leukemia. Blood 2009 ;114 : 3872-3879.
25. Pekarsky Y, Santanam U, Cimmino A, et al. Tcl1 expression inchronic lymphocytic leukemia is regulated by miR-29 and miR-181.Cancer Res 2006; 66: 11590-11593.
26. Pepper C, Lin TT, Pratt G, et al. Mcl-1 expression has in vitro andin vivo signifi cance in chronic lymphocytic leukemia and is associatedwith other poor prognostic markers. Blood 2008 ; 112 : 3807-3817.
27. Sengupta S, den Boon J A, Chen I H, et al. MicroRNA 29c is downregulatedin nasopharyngeal carcinomas, up-regulating mRNAsencoding extracellular matrix proteins. Proc Natl Acad Sci USA2008 ; 105 : 5874-5878.
28. Lagneaux L, Delforge A, Bron D, et al. Chronic lymphocyticleukemic B cells but not normal B cells are rescued from apoptosisby contact with normal bone marrow stromal cells. Blood 1998 ; 91 :2387-2396.
29. Zhao JJ, Lin J, Lwin T, et al. microRNA expression profi le andidentifi cation of miR-29 as a prognostic marker and pathogeneticfactor by targeting CDK6 in mantle cell lymphoma. Blood 2010 ; 115 :2630-2639.